Validation of an automated safety surveillance system with prospective, randomized trial data

Medical Decision Making

Volumn 29, Issue 2, 2009, Pages 247-256

  Matheny, Michael E ^a,c   Morrow, David A ^a   Ohno Machado, Lucila ^a,b   Cannon, Christopher P ^a   Sabatine, Marc S ^a   Resnic, Frederic S ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^c GRECC   (United States)

Author keywords

Cardiology.; Decision support techniques; Risk adjustment; Risk stratification

Indexed keywords

FIBRINOGEN RECEPTOR ANTAGONIST; PLACEBO;

ARTICLE; AUTOMATION; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CLINICAL EVALUATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FIBRINOLYTIC THERAPY; HEART INFARCTION; HOSPITAL READMISSION; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; SENSITIVITY AND SPECIFICITY; STROKE; VALIDATION STUDY;

BAYES THEOREM; DATA INTERPRETATION, STATISTICAL; DECISION SUPPORT TECHNIQUES; FIBRINOLYTIC AGENTS; HUMANS; INTRACRANIAL HEMORRHAGES; MULTICENTER STUDIES AS TOPIC; MYOCARDIAL INFARCTION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SAFETY MANAGEMENT; SENTINEL SURVEILLANCE;

EID: 64549159431     PISSN: 0272989X     EISSN: 1552681X     Source Type: Journal    
DOI: 10.1177/0272989X08327110     Document Type: Article

References (28)

1. Fontanarosa PB, Rennie D., DeAngelis CD Postmarketing surveillance: lack of vigilance, lack of trust. JAMA. 2004 ; 292 (21). 2647-50.
2. Wheeler DJ, Chambers DS Understanding Statistical Process Control. 2 nd ed. Knoxville (TN): SPC Press ; 1992.
3. Spiegelhalter D., Grigg O., Kinsman R., Treasure T. Risk-adjusted sequential probability ratio tests: applications to Bristol, Shipman and adult cardiac surgery. Int J Qual Health Care. 2003 ; 15 (1). 7-13. (Pubitemid 36305557)
4. Shahian DM, Williamson WA, Svensson LG, Restuccia JD, D'Agostino RS Applications of statistical quality control to cardiac surgery. Ann Thorac Surg. 1996 ; 62 (5). 1351.
5. Mohammed MA, Cheng KK, Rouse A., Marshall T. Bristol, Shipman, and clinical governance: Shewhart's forgotten lessons. Lancet. 2001 ; 357 (9254). 463. (Pubitemid 32156152)
6. Williamson GD, Hudson GW A monitoring system for detecting aberrations in public health surveillance reports. Stat Med. 1999 ; 18 (23). 3283-98.
7. Clark DE, Cushing BM, Bredenberg CE Monitoring hospital trauma mortality using statistical process control methods. J Am Coll Surg. 1998 ; 186 (6). 630.
8. Rogers CA, Ganesh JS, Banner NR, Bonser RS Cumulative risk adjusted monitoring of 30-day mortality after cardiothoracic transplantation: UK experience. Eur J Cardiothorac Surg. 2005 ; 27 (6). 1022-9.
9. Grigg OA, Farewell VT, Spiegelhalter DJ Use of risk-adjusted CUSUM and RSPRT charts for monitoring in medical contexts. Stat Methods Med Res. 2003 ; 12 (2). 147-70. (Pubitemid 36347833)
10. Steiner SH, Cook RJ, Farewell VT, Treasure T. Monitoring surgical performance using risk-adjusted cumulative sum charts. Biostatistics. 2000 ; 1 (4). 441-52. (Pubitemid 33213547)
11. Matheny ME, Ohno-Machado L., Resnic FS Risk-adjusted sequential probability ratio test control chart methods for monitoring operator and institutional mortality rates in interventional cardiology. Am Heart J. 2008 ; 155 (1). 114-20. Epub 2007 Oct 17. (Pubitemid 350234774)
12. Matheny ME, Ohno-Machado L., Resnic FS Monitoring device safety in interventional cardiology. J Am Med Inform Assoc. 2006 ; 13 (2). 180-7. Epub 2005 Dec 15. (Pubitemid 43332909)
13. Matheny ME Development of Statistical Methodologies and Risk Models to Perform Real-Time Safety Monitoring in Interventional Cardiology [master's thesis]. Cambridge: Health Sciences & Technology, Massachusetts Institute of Technology ; 2006.
14. Matheny ME, Arora N., Ohno-Machado L., Resnic FS Rare adverse event monitoring of medical devices with the use of an automated surveillance tool. AMIA Annu Symp Proc. 2007: 518-22.
15. Cannon CP, McCabe CH, Wilcox RG, et al. Oral glycoprotein IIb/IIIa inhibition with orbofiban in patients with unstable coronary syndromes (OPUS-TIMI 16) trial. Circulation. 2000 ; 102 (2). 149-56.
16. Sabatine MS, Cannon CP, Gibson CM, et al. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation. N Engl J Med. 2005 ; 352 (12). 1179-89. Epub 2005 Mar 9.
17. Bovill EG, Terrin ML, Stump DC, et al. Hemorrhagic events during therapy with recombinant tissue-type plasminogen activator, heparin, and aspirin for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI), Phase II Trial. Ann Intern Med. 1991 ; 115 (4). 256-65.
18. Hosmer D., Lemeshow S. Applied Logistic Regression. 2 nd ed. San Francisco: Jossey-Bass ; 2000.
19. Matheny ME, Ohno-Machado L., Resnic FS Discrimination and calibration of mortality risk prediction models in interventional cardiology. J Biomed Inform. 2005 ; 38 (5). 367-75. Epub 2005 Mar 26. (Pubitemid 41405807)
20. Siu N., Apostolakis G. Modeling the detection rates of fires in nuclear plants: development and application of a methodology for treating imprecise evidence. Risk Anal. 1986 ; 6 (1). 43-59.
21. Bayes T. Essay towards solving a problem in the doctrine of chances. Philos Trans R Soc Lond. 1763 ; 53: 370-418.
22. Resnic FS, Zou KH, Do DV, Apostolakis G., Ohno-Machado L. Exploration of a Bayesian updating methodology to monitor the safety of interventional cardiovascular procedures. Med Decis Making. 2004 ; 24 (4). 399-407. (Pubitemid 38955765)
23. Standards for Privacy of Individually Identifiable Health Information: Final Rule. Federal Register. 2002 ; 67 (157). 53182-273.
24. Newcombe RG Interval estimation for the difference between independent proportions: comparison of eleven methods. Stat Med. 1998 ; 17 (8). 873-90.
25. Hanley JA, McNeil BJ The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1982 ; 143 (1). 29-36.
26. Lemeshow S., Hosmer DW Jr. A review of goodness of fit statistics for use in the development of logistic regression models. Am J Epidemiol. 1982 ; 115 (1). 92-106.
27. Cauchemez S., Boelle PY, Donnelly CA, et al. Real-time estimates in early detection of SARS. Emerg Infect Dis. 2006 ; 12 (1). 110-3. (Pubitemid 43143545)
28. Zohar S., Chevret S. The continual reassessment method: comparison of Bayesian stopping rules for dose-ranging studies. Stat Med. 2001 ; 20 (19). 2827-43. (Pubitemid 32923210)